Pharmacological Effects and Clinical Prospects of Cepharanthine

Pharmacological Effects and Clinical Prospects of Cepharanthine

Cepharanthine is an active ingredient separated and extracted from <i>Stephania cepharantha</i> Hayata, a Menispermaceae plant. As a bisbenzylisoquinoline alkaloid, cepharanthine has various pharmacological properties, including antioxidant, anti-inflammatory, immunomodulatory, antitumor...

Full description

Bibliographic Details
Main Authors:	Di Liang, Qi Li, Lina Du, Guifang Dou
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Molecules
Subjects:	cepharanthine coronavirus disease 2019 antiviral novel formulations
Online Access:	https://www.mdpi.com/1420-3049/27/24/8933

Similar Items

Pharmacological Activity of Cepharanthine
by: Ke Liu, et al.
Published: (2023-06-01)

Inhibition of porcine deltacoronavirus entry and replication by Cepharanthine
by: Yumei Sun, et al.
Published: (2024-02-01)

Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
by: Di Liang, et al.
Published: (2023-05-01)

A mechanistic updated overview on Cepharanthine as potential anticancer agent
by: YingZheng Wang, et al.
Published: (2023-09-01)

N-glycoproteomic profiling revealing novel coronavirus therapeutic targets potentially involved in Cepharanthine's intervention
by: Wenlin An, et al.
Published: (2022-12-01)

Cepharanthine and Curcumin inhibited mitochondrial apoptosis induced by PCV2
by: Yinlan Xu, et al.
Published: (2020-09-01)

Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
by: Feifei Sun, et al.
Published: (2023-06-01)

Cepharanthine action in preventing obesity and hyperlipidemia in rats on a high-fat high sucrose diet
by: Adnan Iqbal, et al.
Published: (2022-12-01)

Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation
by: Guangrui Chen, et al.
Published: (2023-01-01)

Cepharanthine Alleviates DSS-Induced Ulcerative Colitis via Regulating Aconitate Decarboxylase 1 Expression and Macrophage Infiltration
by: Min-Na Zhang, et al.
Published: (2023-01-01)

Network analysis-based strategy to investigate the protective effect of cepharanthine on rat acute respiratory distress syndrome
by: Chen Chen, et al.
Published: (2022-10-01)

Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
by: Jian Li, et al.
Published: (2022-04-01)

Lung-Targeted Delivery of Cepharanthine by an Erythrocyte-Anchoring Strategy for the Treatment of Acute Lung Injury
by: Jinpeng Zheng, et al.
Published: (2022-08-01)

Cepharanthine inhibits influenza A virus replication by impairing viral polymerase activity and regulating influenza-induced immune response
by: Yinyan Li, et al.
Published: (2024-05-01)

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
by: Ping Jiang, et al.
Published: (2022-07-01)

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
by: Binbin Xia, et al.
Published: (2023-07-01)

Bis-Benzylisoquinoline Alkaloids Inhibit Porcine Epidemic Diarrhea Virus In Vitro and In Vivo
by: Shijuan Dong, et al.
Published: (2022-06-01)

Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
by: Mukesh Kumar, et al.
Published: (2022-01-01)

Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States
by: Erxi Wu, et al.
Published: (2020-12-01)

Correlation analysis of common/severe COVID-19 delta with serum albumin in Zhangjiajie
by: CHEN Yu-zhou, DAI Jing-rong, LI Qian, LIANG Ya-ting, WU Song-lin
Published: (2022-11-01)

Prediction of the mechanism of action of catechin as superoxide anion antioxidants and natural antivirals for COVID-19 infection with in silico study
by: Achmad Zainuddin, et al.
Published: (2022-01-01)

Clinical Characteristics of Asymptomatic and Symptomatic Pediatric Coronavirus Disease 2019 (COVID-19): A Systematic Review
by: Sojung Yoon, et al.
Published: (2020-09-01)

Correlation of clinical, laboratory, ventilation, and outcome parameters in hospitalized Coronavirus Disease 2019-infected patients with computed tomography severity score
by: Mohammed A Ibrahim, et al.
Published: (2023-01-01)

Progress in drug therapy for COVID-19 infection
by: LIU Fang-yuan, SU Xiu-lan
Published: (2020-10-01)

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?
by: Syed Shahzad Hasan, et al.
Published: (2020-03-01)

Experiences and coping mechanisms during the quarantine period among the contacts of COVID-19 patients in India
by: Nitin Joseph, et al.
Published: (2024-05-01)

Comparing COVID-19 RT-PCR results, thorax computed tomography findings, and laboratory results of patients admitted to emergency medicine clinic with clinical symptoms of COVID-19 disease
by: Murat Muratoglu, et al.
Published: (2023-09-01)

Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
by: Ya-Nan Zhang, et al.
Published: (2020-01-01)

A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
by: Sin-Yee Fung, et al.
Published: (2020-01-01)

Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19)
by: Sinem Özyılmaz, et al.
Published: (2020-12-01)

Evaluation of Efficacy and Safety of Clevira as an Add on Drug in Mild to Moderate COVID-19 Positive Patients: A Randomised Control Trial
by: R Narayanababu, et al.
Published: (2022-02-01)

Coronavirus fear assessment using the modified COVID-19 fear scale among Indian dentists practicing in the Delhi NCR region
by: Harsimran Kaur, et al.
Published: (2023-01-01)

Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia
by: Han Li, et al.
Published: (2020-08-01)

Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients’ Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs
by: Francesco Aiello, et al.
Published: (2021-09-01)

Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020
by: Zhen-Dong Tong, et al.
Published: (2020-05-01)

Effectiveness of the ChAdOx1 nCoV-19 Vaccine against Laboratory-confirmed Cases of COVID-19: A Test-negative Case-control Study from Central Kerala, India
by: Geethadevi Madhavikutty, et al.
Published: (2023-10-01)

Therapeutic Efficacy of Ivermectin in Novel Coronavirus Disease-2019 Patient Admitted at the Ward of a Tertiary Care Hospital: A Retrospective Study
by: Kaushick Mishra, et al.
Published: (2023-03-01)

Persistent symptoms of severe and critical COVID-19: A cross-sectional study after more than 120 days from disease onset
by: Mohammed A Alraddadi, et al.
Published: (2023-01-01)

Artificial intelligence-based approaches for COVID-19 patient management
by: Lan Lan, et al.
Published: (2021-05-01)

Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection
by: Oleg V. Maltsev, et al.
Published: (2022-11-01)